Win-55,212-2 and Sr-141716a Alter Nicotine-induced Changes in Locomotor Activity, but Do Not Alter Nicotine-evoked [3h]dopamine Release.
From: Department of Psychological Sciences, University of Missouri, Columbia MO, USA.
Life sciences
- Publish Date: Jan 2007
- ISSN: 0024-3205
- Volume: 80
- Issue: 4
- Pages: 337-44
- Medium: Print
- Language: English
- Citation (JAMA): Rodvelt Kelli R, Bumgarner Dana M, Putnam William C, et al. Win-55,212-2 and Sr-141716a Alter Nicotine-induced Changes in Locomotor Activity, but Do Not Alter Nicotine-evoked [3h]dopamine Release.. Life Sci. Jan 2007;80:337-44
Abstract
Nicotine, the main psychoactive ingredient in tobacco, plays a key role in the development of cigarette smoking addiction. The endocannabinoid system has been demonstrated to have an important role in the motivational and reinforcing effects of drugs. The present study used behavioral and neurochemical techniques to study the interaction of cannabinoid receptors and nicotine pharmacology. In a locomotor activity experiment in rats, the CB(1)/CB(2) cannabinoid receptor agonist WIN-55,212-2 (0.28-2.8 mg/kg) attenuated nicotine (0.4 mg/kg)-induced hyperactivity, but did not alter nicotine (1.0 mg/kg)-induced hypoactivity. In contrast, the selective CB(1) cannabinoid receptor antagonist SR-141716A (1.0 mg/kg) diminished nicotine-induced hypoactivity, but did not alter nicotine-induced hyperactivity. In a neurochemical experiment, rat striatal slices preloaded with [(3)H]dopamine were superfused with WIN-55,212-2 or SR-141716A. A high concentration (100 microM) of WIN-55,212-2 evoked [(3)H]overflow, but this effect was not blocked by the cannabinoid receptor antagonist AM-251. SR-141716A did not evoke [(3)H]overflow, and neither WIN-55,212-2 nor SR-141716A altered nicotine-evoked [(3)H]overflow. Overall, these results indicate a behavioral interaction between cannabinoid receptors and nicotine pharmacology. Likely, WIN-55,212-2 and SR-141716A block nicotine-induced changes in behavior through an indirect mechanism, such as alteration in endocannabinoid regulation of motor circuits, rather than directly through blockade of nicotinic acetylcholine receptors.
Mesh Headings (Keywords): Analgesics, Animals, Benzoxazines, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Drug Antagonism, Male, Morpholines, Motor Activity, Naphthalenes, Nicotine, Piperidines, Pyrazoles, Rats, Rats, Sprague-Dawley, Receptors, Cannabinoid, Tritium
Check for Full Text / PubMed Unique Identifier (PMID): 17067637
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.